Course Evaluation Evidence for Pharmacy Programme Accreditation (2026 Guide)

Pharmacy is one of the seven "sectoral" professions whose training is regulated at EU level, which means a pharmacy programme carries a heavier evidence burden than most degrees: reviewers want proof that your curriculum covers the mandated knowledge and skills, that your experiential placements are quality-assured, and that student feedback actually changes the programme. This guide maps those requirements to the course-evaluation evidence you can produce — and shows where a modern evaluation platform such as Koji adds value over a basic Likert survey, and where it does not.

The three regimes a pharmacy programme answers to

Course evaluation evidence for a pharmacy programme has to satisfy three overlapping frameworks at once. Understanding which one is asking for what keeps your evidence focused.

1. EU Directive 2005/36/EC (minimum training requirements). For automatic recognition across the EU/EEA, a pharmacist qualification must meet the criteria in Article 44 and cover the knowledge and skills listed in Annex V, point 5.6.1. The headline requirements are training of at least five years, including at least four years of full-time theoretical and practical study and a six-month traineeship in a community or hospital pharmacy. Qualifications listed in Annex V, point 5.6.2 are then automatically recognised in any member state. The Directive does not prescribe how you evaluate teaching — but it defines the outcomes your evaluation must show are being delivered, and it makes the six-month traineeship a named, evidence-bearing component.

2. The Standards and Guidelines for Quality Assurance in the European Higher Education Area (ESG 2015). Whatever national agency reviews your programme operates under the ESG. Three standards are directly served by course evaluation: 1.3 (student-centred learning, teaching and assessment), 1.7 (information management — collecting and using data on your programmes), and 1.9 (on-going monitoring and periodic review). Reviewers read these as: you gather student feedback systematically, you analyse it, and you can show what changed as a result.

3. The pharmacy competence layer (PHAR-QA / EAFP). The PHAR-QA project produced a European competence framework for pharmacy practice — a set of competences organised into domains covering patient care and personal/professional competences (the published framework describes on the order of 50 competences across roughly a dozen domains). It is stewarded by the European Association of Faculties of Pharmacy (EAFP). Many faculties now map their curriculum — and increasingly their evaluation questions — to these competences, so that feedback can be read at the level reviewers and employers care about: is the programme producing competent practitioners? For international benchmarking, some schools also reference ACPE standards, but the EU regime above is the binding one in Europe.

What reviewers actually ask for

Across national pharmacy accreditation and ESG-based programme reviews, the evaluation-related evidence requests cluster into six recurring asks:

• Systematic student feedback at module and programme level, not just a satisfaction score.
• Evidence that experiential placements (the six-month traineeship and any earlier placements) are evaluated, including the student experience of the placement and preceptor.
• Feedback mapped to intended learning outcomes and competences, so coverage of Annex V.5.6.1 knowledge and skills is demonstrable.
• Evidence of closing the loop — documented changes made in response to feedback, reported back to students.
• Longitudinal data showing monitoring over successive cohorts (ESG 1.9).
• Fair, comparable, and data-protection-compliant collection.

Mapping accreditation requirements to Koji outputs

Accreditation / QA requirement	Evidence a course-evaluation platform can produce
Directive Annex V.5.6.1 knowledge & skills coverage	Module feedback tagged to intended learning outcomes, so you can show each mandated area is taught and experienced as intended
Six-month traineeship / experiential placement quality (Directive Art. 44)	Dedicated placement and preceptor evaluations — AI-moderated interviews with students on placement capture what a Likert form misses
ESG 1.3 student-centred learning	Formative, mid-module feedback that feeds back into teaching within the same cohort
ESG 1.7 information management	A single system of record for evaluation data across modules, cohorts and years
ESG 1.9 on-going monitoring & periodic review	Longitudinal cohort dashboards showing trends over successive intakes
PHAR-QA competence domains	Feedback tagged to competence domains, enabling competence-level reporting
Closing the loop / continuous improvement	Action tracking: documented responses to feedback, with student-facing "you said, we did" updates
Fair, comparable evidence	Standardized, bias-aware moderation so responses are comparable across modules and cohorts
GDPR / data protection	EU/GDPR-native handling, anonymity by design, and small-cohort re-identification safeguards

The point of the table is not that software replaces academic judgement — it does not. It is that each row is a question an auditor can ask, and each right-hand cell is an artefact you can hand them without a scramble.

The experiential-placement gap most surveys miss

Pharmacy's six-month traineeship is where standard course evaluation is weakest and where the evidence matters most. A student on placement is not sitting in your lecture theatre; their experience is shaped by a preceptor, a workplace, and a set of real patients. A five-point "rate your placement" question tells you almost nothing actionable. What a reviewer wants — and what improves the programme — is the why: was the student given graduated responsibility, was supervision adequate, did the placement let them practise the competences the Directive requires?

This is precisely where AI-moderated conversational evaluation earns its place. Instead of a flat rating, Koji conducts a short, standardized interview that adapts its follow-up questions to each student's answers, then analyses the transcripts automatically into themes with representative quotes and prevalence. For placements — heterogeneous, qualitative, and hard to compare — that turns a weak evidence base into a defensible one. The same AI interview engine that powers Koji's main research platform runs these conversations at cohort scale.

When a platform is not the right answer

Honesty serves this audience, so three caveats:

1. Competence assessment is not course evaluation. Whether a student is competent is decided by your assessment system — OSCEs, practical exams, portfolio judgement — not by asking them how they felt about a module. Course evaluation evidences the quality and delivery of the programme; it does not certify competence. Do not present one as the other to a panel.
2. A basic survey may suffice for basic compliance. If your national regulator only requires a standardized Likert instrument with response-rate reporting, a well-run traditional survey tool (or your existing EvaSys-style system) can meet the letter of the requirement. The case for a conversational platform is strongest when qualitative depth, placement evaluation, and closing-the-loop reporting are what you are graded on.
3. National templates win. Where a regulator mandates a specific instrument or question set, use it. A modern platform should host the mandated questions and add depth around them — not replace a required instrument.

A worked example: evidencing the six-month traineeship

Suppose a national pharmacy reviewer asks: "How do you assure the quality of your students' six-month traineeships?" A weak answer is a placement satisfaction average of 4.1 out of 5. A strong answer looks like this. Each student completes a short standardized evaluation at the end of the traineeship in which the AI moderator adapts its questions to their answers — probing whether they were given graduated responsibility, whether supervision was adequate, and which Annex V.5.6.1 skills they were able to practise. The transcripts are analysed automatically into themes: perhaps "insufficient exposure to compounding" recurs across a cluster of community-pharmacy placements. That theme, with representative anonymised quotes and its prevalence across the cohort, becomes a finding. The programme team responds by adjusting placement agreements with those sites, logs the action, and reports it back to students. At the next review, the same evaluation shows the theme has receded. That full chain — signal, analysis, action, re-measurement — is exactly what ESG 1.9 means by on-going monitoring, and it is far more persuasive to a panel than any single score.

A practical evidence checklist

Before a review, a pharmacy programme should be able to produce, on request:

1. Module-level evaluation results for every module, tagged to learning outcomes.
2. Placement/traineeship evaluations covering the six-month requirement.
3. A competence-mapped summary aligned to PHAR-QA domains.
4. Longitudinal trend data across at least three cohorts.
5. A closing-the-loop log: feedback in, action taken, students informed.
6. A data-protection statement covering anonymity, retention and lawful basis.

If you can hand a panel those six artefacts, your evaluation evidence is in good shape — regardless of which tool produced them.

Related resources

• Course Evaluation Evidence for WFME Medical School Accreditation
• Course Evaluation Evidence for Nursing & Health Professions Accreditation
• Turning Student Feedback into ESG / ENQA Accreditation Evidence
• Writing the Self-Evaluation Report: Course Evaluation Evidence
• Related reading: Why your pharmacy degree is half placement but your evaluation is all lecture hall

Ready to build accreditation-ready pharmacy evaluation evidence? Explore Koji for Education.